Suppr超能文献

低纤维蛋白原水平对 TBI 患者住院死亡率和 6 个月功能结局的影响:一项单中心经验。

Effect of low fibrinogen level on in-hospital mortality and 6-month functional outcome of TBI patients, a single center experience.

机构信息

Trauma Research Center, Department of Neurosurgery, Shahid Rajaee Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.

Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv (KNU), Kyiv, Ukraine.

出版信息

Neurosurg Rev. 2024 Feb 28;47(1):95. doi: 10.1007/s10143-024-02326-y.

Abstract

In patients affected by traumatic brain injury (TBI), hypofibrinogenemia within the initial hours of trauma can be expected due to vascular and inflammatory changes. In this study, we aimed to evaluate the effect of hypofibrinogenemia on the in-hospital mortality and 6-month functional outcomes of TBI patients, admitted to Rajaee Hospital, a referral trauma center in Shiraz, Iran. This study included all TBI patients admitted to our center who had no prior history of coagulopathy or any systemic disease, were alive on arrival, and had not received any blood product before admission. On admission, hospitalization, imaging, and 6-month follow-up information of included patients were extracted from the TBI registry database. The baseline characteristics of patients with fibrinogen levels of less than 150 mg/dL were compared with the cases with higher levels. To assess the effect of low fibrinogen levels on in-hospital mortality, a uni- and multivariate was conducted between those who died in hospital and survivors. Based on the 6-month GOSE score of patients, those with GOSE < 4 (unfavorable outcome) were compared with those with a favorable outcome. A total of 3049 patients (84.3% male, 15.7% female), with a mean age of 39.25 ± 18.87, met the eligibility criteria of this study. 494 patients had fibrinogen levels < 150 mg/dl, who were mostly younger and had lower average GCS scores in comparison to cases with higher fibrinogen levels. By comparison of the patients who died during hospitalization and survivors, it was shown that fibrinogen < 150 mg/dl is among the prognostic factors for in-hospital mortality (OR:1.75, CI: 1.32:2.34, P-value < 0.001), while the comparison between patients with the favorable and unfavorable functional outcome at 6-month follow-up, was not in favor of prognostic effect of low fibrinogen level (OR: 0.80, CI: 0.58: 1.11, P-value: 0.19). Hypofibrinogenemia is associated with in-hospital mortality of TBI patients, along with known factors such as higher age and lower initial GCS score. However, it is not among the prognostic factors of midterm functional outcome.

摘要

在创伤性脑损伤(TBI)患者中,由于血管和炎症变化,创伤最初几小时内可出现低纤维蛋白原血症。在这项研究中,我们旨在评估低纤维蛋白原血症对伊朗设拉子 Rajaee 医院收治的 TBI 患者住院期间死亡率和 6 个月功能结局的影响,该中心是一家转诊创伤中心。这项研究纳入了所有无凝血功能障碍或全身性疾病既往史、入院时存活且入院前未接受任何血液制品的我院收治的 TBI 患者。在入院时、住院期间、影像学检查和 6 个月随访时,从 TBI 登记数据库中提取纳入患者的信息。比较纤维蛋白原水平低于 150mg/dL 的患者与纤维蛋白原水平较高的患者的基线特征。为了评估低纤维蛋白原水平对住院期间死亡率的影响,对住院期间死亡的患者和幸存者进行了单变量和多变量分析。根据患者的 6 个月 GOSE 评分,GOSE<4(预后不良)的患者与预后良好的患者进行了比较。共纳入 3049 名患者(84.3%男性,15.7%女性),平均年龄 39.25±18.87 岁,符合本研究的入选标准。494 名患者的纤维蛋白原水平<150mg/dl,与纤维蛋白原水平较高的患者相比,他们更年轻,平均 GCS 评分更低。与住院期间死亡的患者和幸存者相比,纤维蛋白原<150mg/dl 是住院期间死亡率的预后因素之一(OR:1.75,95%CI:1.32-2.34,P 值<0.001),而在 6 个月随访时比较功能结局良好和不良的患者,低纤维蛋白原水平对预后没有影响(OR:0.80,95%CI:0.58-1.11,P 值:0.19)。低纤维蛋白原血症与 TBI 患者的住院期间死亡率相关,与较高年龄和较低初始 GCS 评分等已知因素相关。然而,它不是中期功能结局的预后因素之一。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验